Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch

Executive Summary

Repeat antibiotic entrepreneurs raised $33m to launch Qpex with assets from The Medicines Co. Also, Taiho increases VC fund to $300m and TP Therapeutics raises $80m.

Advertisement

Related Content

Finance Watch: VC Tally Hits $14.5bn For 2018, Beating 2017 With A Quarter Left To Go
Alarm As Novartis Exits Antibiotics Space
Melinta Expands Portfolio, TMC Narrows Focus To LDL Reduction With Anti-Infective Deal
US Approval Of Vabomere Could Help Alleviate TMC's Financial Troubles
AMR Roundtable: The Push And Pull Of Antimicrobial Development Incentives (Part 1)
Raptor Buy Bolsters Horizon's Orphan Business As Primary Care Foots The Bill
CARB-X Partnership Puts Antibiotics' Future In Biotech Startups' Hands
Circle Of Life: Raptor Buys Quinsair After Its Return To Original Developer
BARDA backs Medicines/Rempex antibiotic with $90m award
Medicines Company gains anti-infectives in $140m Rempex buy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC124040

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel